UniProt ID | RL40_MOUSE | |
---|---|---|
UniProt AC | P62984 | |
Protein Name | Ubiquitin-60S ribosomal protein L40 | |
Gene Name | Uba52 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 128 | |
Subcellular Localization |
Ubiquitin: Cytoplasm. Nucleus. 60S ribosomal protein L40: Cytoplasm. |
|
Protein Description | Ubiquitin: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in lysosomal degradation; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling.; 60S ribosomal protein L40: Component of the 60S subunit of the ribosome.. | |
Protein Sequence | MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGIIEPSLRQLAQKYNCDKMICRKCYARLHPRAVNCRKKKCGHTNNLRPKKKVK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Ubiquitination | --MQIFVKTLTGKTI --CEEEEEECCCCEE | 27.37 | - | |
6 | Acetylation | --MQIFVKTLTGKTI --CEEEEEECCCCEE | 27.37 | - | |
7 | Phosphorylation | -MQIFVKTLTGKTIT -CEEEEEECCCCEEE | 25.01 | 27600695 | |
9 | Phosphorylation | QIFVKTLTGKTITLE EEEEEECCCCEEEEE | 41.69 | 26643407 | |
11 | Ubiquitination | FVKTLTGKTITLEVE EEEECCCCEEEEEEC | 31.36 | - | |
12 | Phosphorylation | VKTLTGKTITLEVEP EEECCCCEEEEEECC | 22.12 | 27180971 | |
14 | Phosphorylation | TLTGKTITLEVEPSD ECCCCEEEEEECCCC | 23.30 | 27742792 | |
20 | Phosphorylation | ITLEVEPSDTIENVK EEEEECCCCHHHHHH | 33.60 | 26745281 | |
22 | Phosphorylation | LEVEPSDTIENVKAK EEECCCCHHHHHHHH | 34.23 | 26745281 | |
27 | Ubiquitination | SDTIENVKAKIQDKE CCHHHHHHHHHCCCC | 56.39 | - | |
29 | Ubiquitination | TIENVKAKIQDKEGI HHHHHHHHHCCCCCC | 34.87 | - | |
33 | Acetylation | VKAKIQDKEGIPPDQ HHHHHCCCCCCCHHH | 41.27 | - | |
33 | Ubiquitination | VKAKIQDKEGIPPDQ HHHHHCCCCCCCHHH | 41.27 | - | |
48 | Acetylation | QRLIFAGKQLEDGRT HEEEEEEEECCCCCC | 48.56 | - | |
48 | Ubiquitination | QRLIFAGKQLEDGRT HEEEEEEEECCCCCC | 48.56 | - | |
55 | Phosphorylation | KQLEDGRTLSDYNIQ EECCCCCCCCCCCCC | 35.82 | 24925903 | |
57 | Phosphorylation | LEDGRTLSDYNIQKE CCCCCCCCCCCCCCH | 37.12 | 17242355 | |
57 | Phosphorylation | LEDGRTLSDYNIQKE CCCCCCCCCCCCCCH | 37.12 | 24925903 | |
59 | Phosphorylation | DGRTLSDYNIQKEST CCCCCCCCCCCCHHH | 15.70 | 24925903 | |
63 | Ubiquitination | LSDYNIQKESTLHLV CCCCCCCCHHHHHHH | 50.24 | - | |
63 | Acetylation | LSDYNIQKESTLHLV CCCCCCCCHHHHHHH | 50.24 | - | |
65 | Phosphorylation | DYNIQKESTLHLVLR CCCCCCHHHHHHHHH | 43.22 | 27742792 | |
66 | Phosphorylation | YNIQKESTLHLVLRL CCCCCHHHHHHHHHH | 21.20 | 22324799 | |
76 | ADP-ribosylation | LVLRLRGGIIEPSLR HHHHHCCCCCCHHHH | 15.97 | - | |
88 | Acetylation | SLRQLAQKYNCDKMI HHHHHHHHCCCCHHH | 32.59 | 22826441 | |
93 | Ubiquitination | AQKYNCDKMICRKCY HHHCCCCHHHHHHHH | 32.15 | - | |
93 | Acetylation | AQKYNCDKMICRKCY HHHCCCCHHHHHHHH | 32.15 | 22826441 | |
98 | "N6,N6,N6-trimethyllysine" | CDKMICRKCYARLHP CCHHHHHHHHHHHCH | 27.47 | - | |
98 | Methylation | CDKMICRKCYARLHP CCHHHHHHHHHHHCH | 27.47 | - | |
115 | S-nitrosocysteine | VNCRKKKCGHTNNLR HCCCHHCCCCCCCCC | 7.11 | - | |
115 | Glutathionylation | VNCRKKKCGHTNNLR HCCCHHCCCCCCCCC | 7.11 | 24333276 | |
115 | S-nitrosylation | VNCRKKKCGHTNNLR HCCCHHCCCCCCCCC | 7.11 | 21278135 | |
124 | Acetylation | HTNNLRPKKKVK--- CCCCCCCCCCCC--- | 59.81 | 23864654 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
65 | S | Phosphorylation |
| - |
65 | S | ubiquitylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL40_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FOXP3_MOUSE | Foxp3 | physical | 22579476 | |
WRIP1_HUMAN | WRNIP1 | physical | 27062441 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...